GENEVA, Oct. 30 -- NANJING GENELEAP BIOTECHNOLOGY CO., LTD. filed a patent application (CN2026/092367) for “MRNA VACCINE FOR TREATING OR PREVENTING DISEASES ASSOCIATED WITH HPV INFECTION, PREPARATION METHOD THEREFOR, AND USE THEREOF”. With publication no. WO/2026/223719, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/37
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....